Fingerprint
Dive into the research topics of 'Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically